2024年1至12月份，万东医疗的营业收入构成为：医疗器械制造业占比93.68%，其他业务占比6.32%。 截至发稿，万东医疗市值为114亿元。 每经AI快讯，万东医疗（SH 600055，收盘价：16.22元）12月1日晚间发布公告称，截至2025年12月1 日，公司通过集中竞价交易方式累计回购股份约130万股，已回购股份占公司总股本的比例为 0.1847%，购买的最高价为17.99元/股、最低价为16.11元/股，已支付的总金额约为2200万元。 每经头条（nbdtoutiao）——5年期大面积下线，3年期利率低至1.5%仍一单难求：要么"售罄"要么"额度 紧张"！中长期大额存单为何在消失？ （记者 王晓波） ...

格隆汇12月1日丨万东医疗(600055.SH)公布，截至2025年12月1日，公司通过集中竞价交易方式累计回 购股份129.88万股，已回购股份占公司总股本的比例为0.1847%，购买的最高价为17.99元/股、最低价为 16.11元/股，已支付的总金额为2199.57万元（不含交易费用）。 ...

张英 医疗反腐风暴渐渐平息，医疗设备经销商却未能放松，他们面临更大的考验——集采。 11月，多位医疗设备经销商找到张震，想聊聊转型的可能。几年前，当安徽、福建率先开展医疗设备省 级集采时，张震就决定陆续放弃医疗设备经销业务，现在已转型到投资行业。 医疗设备集采最初于2020年开始在安徽、福建施行，不过此后几年跟进的省份较少，直至近一年来情况 出现变化——据经济观察报统计，全国至少已有14个省份开展医疗设备集采。 医疗设备包括常见的超声、CT、数字X线（DR）、呼吸机，也包括一般人不太了解的磁共振（MR）、 血管造影系统、手术机器人、放疗设备等。 与药品和耗材直接用于治疗患者不同，医疗设备多是医生诊断的辅助工具，相当于医生的眼睛。 患者对医疗设备的价格感知较弱，它的价格直接影响到的是医疗机构的采购成本，进而常以间接的方式 影响患者的检查等费用。 在2023年开始的医疗反腐风暴中，医疗设备采购中存在的贪腐受到高度关注。多位受访者认为，这是近 一年来多省陆续开展医疗设备集采的重要背景，未来医疗设备集采会持续扩围。 这场集采浪潮正重塑医疗设备万亿市场，那些曾价值上百万元、千万元的大块头设备在这场集采中不断 刷新最低价 ...

Core Points - The company has received a medical device registration certificate from the National Medical Products Administration, which is expected to enhance its product structure and meet market demand [1][2]. Group 1: Medical Device Registration - The registration certificate number is Guo Xie Zhu Ren 20253062378, and it pertains to the X-ray computed tomography device named TurboTom 9 PRO [1]. - The product consists of several components, including a high-voltage generator, X-ray tube assembly, collimator, scanning frame, patient support, detector, control console, image processing system, power distribution cabinet, camera, and accessories [1]. Group 2: Impact on the Company - The acquisition of the registration certificate is expected to further enrich the company's product offerings and enhance its core competitiveness in the market [2].

Group 1 - Hekang New Energy's subsidiary received a government subsidy of 6 million yuan, accounting for 58.27% of the company's latest audited net profit attributable to shareholders [1] - Anhui Construction won two major EPC projects with a total bid price of 2.603 billion yuan [2] - Tianrun Dairy's wholly-owned subsidiary received a government subsidy of 7.9094 million yuan, representing 18.12% of the company's audited net profit for 2024 [2] Group 2 - Yunnan Gold's subsidiary obtained a mining license for the Xinxiao County Tanxi Tungsten Mine, with a production capacity of 990,000 tons per year [5][22] - Yanzhou Coal Energy plans to acquire 100% equity of a high-end support company for 345 million yuan [6] - Heng Rui Pharmaceutical received approval for multiple drug clinical trials, including Sulfate Amexitin tablets [8] Group 3 - Huazhi Jie plans to invest 157 million yuan to establish five wholly-owned subsidiaries to expand its global strategy [1] - Junting Hotel's controlling shareholder is planning a change of control, leading to a continued suspension of trading [4] - Funi Technology's shareholder plans to reduce its stake by up to 1.68% [10] Group 4 - Midea Group's subsidiary received a government subsidy of 6 million yuan, which is 58.27% of the company's latest audited net profit [1] - Hunan Gold's subsidiary obtained a mining license for tungsten, iron, and silver, with a production scale of 990,000 tons per year [5][22] - Xin Hua Pharmaceutical received approval for the listing application of Acetate Prednisone raw material [24][25] Group 5 - Zhejiang Pharmaceutical plans to spin off its subsidiary for a listing on the Hong Kong Stock Exchange [28] - Kesheng Technology plans to invest 61.2 million yuan to acquire 51% of Shenzhen Guanding [30] - Tian Shan Aluminum's 1.4 million tons electrolytic aluminum green low-carbon energy efficiency improvement project has commenced production [38]

Group 1 - The core point of the article is that Wandong Medical (600055.SH) has received a medical device registration certificate from the National Medical Products Administration for its X-ray computed tomography equipment [1] Group 2 - The product mentioned is specifically an X-ray computed tomography device, indicating a focus on advanced imaging technology in the medical field [1] - The approval from the regulatory body suggests that the company is progressing in its product development and compliance with industry standards [1] - This development may enhance the company's market position and potential revenue streams in the medical imaging sector [1]

Group 1 - Company WanDong Medical (SH 600055) announced the receipt of a medical device registration certificate from the National Medical Products Administration for its "X-ray computed tomography equipment" [1] - For the fiscal year 2024, WanDong Medical's revenue composition is projected to be 93.68% from the medical device manufacturing sector and 6.32% from other businesses [1] - As of the report, WanDong Medical has a market capitalization of 11.4 billion yuan [1]

Core Viewpoint - Wandong Medical (600055.SH) has recently received a medical device registration certificate from the National Medical Products Administration for its X-ray computed tomography equipment [1] Group 1 - The company has been granted a registration certificate for its X-ray computed tomography device, indicating regulatory approval for the product [1]

Core Viewpoint - Wandong Medical (600055) has recently received the Medical Device Registration Certificate from the National Medical Products Administration for its X-ray Computed Tomography Equipment [1] Company Summary - The product approved is X-ray Computed Tomography Equipment, indicating a significant development in Wandong Medical's product offerings [1]

格隆汇11月27日丨万东医疗(600055.SH)公布，公司于近日收到国家药品监督管理局颁发的《中华人民 共和国医疗器械注册证》。产品名称：X射线计算机体层摄影设备，注册证编号：国械注准 20253062378，型号、规格：TurboTom 9 PRO，结构及组成：产品由高压发生器、X射线管组件、限束 器、扫描架、患者支架、探测器、控制台、图像处理系统、电源分配柜、摄像头和附件组成。 上述注册证的取得，有助于进一步丰富公司产品结构，不断满足市场需求，有利于进一步增强公司的核 心竞争力。 ...